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Urine from patients with ketoacidosis was found to contain a number of aliphatic 3-hydroxy dicarboxylic acids. The acids were purified by silicic acid chromatography and their structures determined by gas chromatography-mass spectrometry of different derivatives. The major compound was 3-hydroxydecanedioic acid. Minor compounds were 3-hydroxyoctanedioic acid, 3-hydroxyoctenedioic acid, 3-hydroxydecenedioic acid, 3-hydroxydodecanedioic acid, 3-hydroxydodecenedioic acid, 3-hydroxytetradecenedioic acid, and 3-hydroxytetradecadienedioic acid. The excretion of 3-hydroxydecanedioic acid correlated positively with the excretion of hexanedioic acid, another metabolite constantly found in ketoacidosis (Pettersen et al., C/in. Chim. Acta 38: [17] [18] [19] [20] [21] [22] [23] [24] 1972) . We suggest that the 3-hydroxy dicarboxylic acids are formed from fatty acids by a combination of w-oxidation and incomplete (3-oxidation.
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In ketoacidosis due to diabetes mellitus or of other etiology, urine does not contain merely the three classic metabolites 3-hydroxybutyric acid, 3-oxobutyric acid, and acetone. Pettersen et al.
(1) identified hexanedioic acid (adipic acid), octanedioic acid (suberic acid), and occasionally pentanedioic acid (glutaric acid) and butanedioic acid (succinic acid) in urines from patients with ketoacidosis of different etiologies. Another series of new metabolites was described by Landaas (2) , who identified 3-hydroxyisobutyric acid, 2-methyl-3-hydroxybutyric acid, and 3-hydroxyisovaleric acid. The increased excretion of these compounds was shown to be the result of inhibition by ketone bodies and their CoA-derivatives of enzymes involved in the degradation of branched-chain amino acids (3) .
A detailed knowledge of secondary metabolites excreted in ketoacidosis is necessary for a correct interpretation of an organic acid profile in metabolic disease. In this report, we describe the identification of 3-hydroxydecanedioic acid and related homologues in urine samples from patients with ketoacidosis.
Methods and Materials
Analysis of Organic Acids in Urine
We obtained urine samples from patients with ketoacidosis due to diabetes mellitus or undefined metabolic disorders. Samples were stored at -20 #{176}C and analyzed within one week after collection.
The method for analysis of organic acids in urine has been described before (4 
Results
Preparation of the Major Unknown Compound
An unknown compound constantly observed in urine samples from patients with ketoacidosis ( Figure 1 ) was purified as the methyl ester by column chromatography on silicic acid. It was eluted in diethyl ether/n-heptane, 34/66 by vol. We obtained 4.8 mg of a fraction that contained about 90% of the unknown compound, the major contaminant being a homologue.
Identification of the Major Unknown Compound
The trimethylsilyl derivative of the unknown compound with the molecular mass and known fragmentations of tnmethylsilyl derivatives (see Table 1 ). 
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with a relative molecular mass of 327 ( Figure 3 and Table 2 ). The corresponding unlabeled derivative had a relative molecular mass of 318. The resulting mass difference of 9 is consistent with the presence of one trimethylsilyl group.
We calculated the number of methylene groups (seven) by subtracting the mass of two carboxyl groups and one hydnoxymethylene group from the mass of the undenivatized compound.
However, the structure of the aliphatic part of the molecule was more directly shown by dehydratization and catalytic hydrogenation, which yielded n-decanedioic acid, the mass spectrum of which was available for comparison (5) . This result also showed that there were no branches in the carbon chain.
The position of the hydroxyl group was shown by specific fragmentations in the mass spectra (Figures 2 and 3 ). In the spectrum of the tnimethylsilyl (TMS) derivative, there was an ion at m/e 303, i.e., M-CH2.COOTMS, and an ion at m/e 233, CHOTMS-CH2-COOTMS.
In the spectrum of the methyl ester tnimethylsilyl ether, there was an intense ion at m/e 175, CHOTMS.CH2.COOCH3, and an ion at m/e 245, CHOTMS.(CH2)6-COOCH3.
All fragments showed the expected shifts in mass for the differently labeled compounds (Figures 2 and 3) . From these observations, the position of the hydroxyl group was assigned to carbon atom 3. In conclusion, the major unknown compound was identified as 3-hydroxydecanedioic acid.
Identification of Saturated and Unsaturated Homologues to 3-Hydroxydecanedioic Acid
In the course of the preparative work, we observed some homologues to 3-hydroxydecanedioic acid. They were all 3-hydroxy acids, as shown by the ion at m/e 175 in the mass spectra of the methyl ester tnimethylsilyl ether derivatives. The following pairs of compounds were detected by gas chromatography-mass spectrometry in different fractions from the silicic acid column chromatography:
3-hydroxyoctanedioic acid and 3-hydroxyoctenedioic acid, 3-hydroxydecanedioic acid and 3-hydroxydecenedioic acid, 3-hydroxydodecanedioic acid and 3-hydroxydodecenedioic acid, as well as 3-hydroxytetradecenedioic acid and 3-hydroxytetradecadienedioic acid. We did not determine double-bond positions and stereochemistry.
Excreted Amounts of 3-Hydroxydecanedioic Acid
3-Hydroxydecanedioic acid is occasionally observed, in concentrations up to 20 zmol/L, in urine samples from healthy individuals.
The acid was present in concentrations of 10 to 400 tmol/L in urine samples from patients with ketoacidosis. Correlation with the concentration of hexanedioic acid was good, as shown in Figure 4 . The excretion of 3-hydroxydecanedioic acid was about half as much as for hexanedioic acid. The amount of excretion of the other homologues combined was of the same order of magnitude as for 3-hydroxydecanedioic acid.
Discussion
3-Hydroxydecanedioic
acid was isolated from the urine of patients with ketoacidosis, and appears to be constantly present in ketoacidosis of different etiologies. We confirmed its structure by mass spectrometry of several derivatives, and by the fact that n-decanedioic acid was obtained after dehydratization and catalytic hydrogenation of the parent compound. Saturated and unsaturated homologues with eight, 12, and 14 carbon atoms were also present, which indicates that the dicarboxylic acids found are metabolites of fatty acids. of fatty acids appears to be a minor pathway under normal conditions.
In liver slices from normal rats it accounts for less than 5% of the total oxidation of stearic acid (7) . This pathway seems to be quantitatively more important in ketoacidosis, at least in absolute terms. hexanedioic acid, given in the diet or by injection, was largely excreted unmetabolized (11, 12) . In vitro experiments have shown that long-chain dicarboxylic acids are not activated and transported into the mitochondnia as readily as fatty acids, and that they have to compete with fatty acids for the same enzyme systems (13, 14) . In a metabolic situation with high fat utilization and formation of long-chain dicarboxylic acids, dicarboxylic acids may be to a considerable extent oxidized through the cytoplasmic fl-oxidation system. The activity of these enzymes has not been studied with dicarboxylic acids as substrate, but it is known that cytoplasmic fl-oxidation of long-chain fatty acids results in accumulation of fatty acids of medium chain length as well as 3-hydroxy acids (15) . Cytoplasmic enzymes are also less efficient than the mitochondrial enzymes with substrates such as dodecanoyl-CoA and octanoyl-CoA (16) . An intermittent excretion of hexanedioic acid and octanedioic acid has been reported in carnitine deficiency (17, 18) . We have recently observed two children who had no ketoacidosis but excreted very impressive amounts of hexanedioic acid, octanedioic acid, 3-hydroxydecanedioic acid, and the related homologues.
Both have a muscular disease, one of them with a progressive encephalopathy. Therefore, it is unlikely that either the metabolites now reported or hexanedioic acid and octanedioic acid are formed as a result of an inhibition of the fl-oxidation by ketone bodies; rather, a defect in transport of fatty acids into the mitochondria will result in an increase in w-oxidation and excretion of dicarboxylic acids. In the two metabolic situations discussed above, w-oxidation is increased because of a high fatty-acid concentration in the cytoplasm.
Another role of the w-oxidation system is in the degradation of fatty acids with structures that block the fl-oxidation system. Examples of such fatty acids are cyclopropane fatty acids (19) , cyclopropene fatty acids ((20) , methyl-branched fatty acids (21) , acetylenic fatty acids (22) , and possibly mycolic acids (23) . By a combination of w-and fl-oxidation these acids give rise to short-or medium-chain dicarboxylic acids, which retain the structure unmodified or slightly modified that blocks the fl-oxidation system. Finally, we note that dicarboxylic acids of longer chain length such as cis-5-dodecenedioic acid and cis-5-tetradecenedioic acids, which we found in the urine of a fatal case of acidosis (5), have not been found in cases of ketoacidosis.
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